Adjuvant Chemotherapy and the Role of Chemotherapy Resistance Testing for Stage I Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Adjuvant Chemotherapy and the Role of Chemotherapy Resistance Testing for Stage I Non–Small Cell Lung Cancer

Published:2007-05 Issue:2 Volume:17 Page:287-299
ISSN:1547-4127
Container-title:Thoracic Surgery Clinics
language:en
Short-container-title:Thoracic Surgery Clinics

Author:

d'Amato Thomas A.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Surgery

Reference29 articles.

1. Cancer facts and figures 2006;American Cancer Society,2006

2. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710–7.

3. Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer;N Engl J Med,2004

4. Randomized clinical one page of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): report of cancer and leukemia Group B (CALGB) protocol 9633;Strauss;J Clin Oncol,2004

5. A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR.10;Winton;N Engl J Med,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The total scale for prognosis of survival patients with early stages of non-small cell lung cancer;Klinical Informatics and Telemedicine;2014-07-17

2. Adjuvant Chemotherapy Based on the In Vitro Histoculture Drug Response Assay for Non-small Cell Lung Cancer Improves Survival;Journal of Thoracic Oncology;2010-09

3. Survival Among Patients with Platinum Resistant, Locally Advanced Non-Small Cell Lung Cancer Treated with Platinum-Based Systemic Therapy;Annals of Surgical Oncology;2009-07-16